Case series:mesenchymal stem cells therapy

2 trials

Sponsors

Second Hospital of University of South China, Hengyang, Nanjing Second Hospital

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Phase 1

Cancelled by the investigator Umbilical cord mesenchymal stem cells (hucMSCs) in the treatment of high risk novel coronavirus pneumonia (COVID-19) patients

RecruitingChiCTR2000030300

Nanjing Second HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-20Updated: 2020-04-20

Unknown Phase

The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19)

RecruitingChiCTR2000030020

Second Hospital of University of South China, HengyangNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-06Updated: 2020-02-25